drugset / Trial / NCT00667719
A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension
NaSingle-groupOpen-labelTreatment
Summary
This study tested the safety of the combination of aliskiren/amlodipine/hydrochlorothiazide in participants with essential hypertension.
Timeline
- Start
- 2008-06-05
- Primary completion
- 2009-10-05
- Completion
- 2009-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | 300 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |